Cancer remains the second leading cause of mortality and accounts for approximately one of every six deaths all around the world. Regardless of the encouraging levels of survival benefit as a result of screening and early detection, total cancer bereavements are rising on a global scale. 1 One of the prime reasons for this phenomenon is that the screening of tumors has been pointed to only a few organs that foster tumors of sufficient prevalence. This leaves most of the cancer types unseen.
Henceforth, filling this gap in cancer control can have an enormous impact on morbidity as well as mortality reduction in cancer patients. 1 One such conceptually intriguing approach for cancer control is universal cancer screening and a multi-organ approach. 1 The figure below provides several advantages of the universal cancer screening approach: …
